AphasiaBank Protocol French Marcotte Controls


Karine Marcotte
École d’orthophonie et d’audiologie
Université de Montréal

Participants: 14 controls
Type of Study: AphasiaBank Discourse Protocol -- French
Location: Montréal
Media type: audio
DOI: doi:10.21415/GWJV-KW06

Browsable database

Download transcripts

Media folder

Citation information

Corpus Description: Participants without brain damage

Aim of the project: Investigate typical spoken discourse abilities in Quebec French neurotypical speakers. Examine the effect of linguistic, cognitive, sociodemographics and social cognition abilities on spoken discourse.

A group of neurotypical individuals speaking Quebec French divided in 8 age groups: 18 to 25 y.o., 26 to 35 y.o., 36 to 45 y.o., 46 to 55 y.o., 56 to 65 y.o., 66 to 75 y.o., 76 to 85 y.o., 86 y.o. and plus. All participants will be tested twice, at a six-month interval.

Discourse tasks

Other language abilities

Neuropsychological profile:

  • A cognitive screening test will be conducted using the MoCA.
  • Verbal divergent thinking will be assessed using three verbal fluency tasks from the MEC.
  • Nonverbal divergent thinking will be assessed using the Ruff Figural Fluency Test
  • Mental flexibility will be assessed using the Alphaflex and the Trail Making Test (TMT), parts A and B. Alphaflex is more recent and less widely used than the TMT, but it requires flexibility on only one sequence (the alphabet) and does not have a visual component nor a motor response.
  • Working memory will be assessed using the Digit Span Task from the Canadian WAIS-IV.
  • Short- and long-term verbal memory will be tested with the Rey Auditory Verbal Learning Test.
  • Inhibitory control will be tested using the Stroop Victoria Test.
  • Nonverbal intelligence will be assessed using the Raven’s Coloured Progressive Matrices (RCPM) of the WAB-R (to assess divergent construct).

    Acknowledgements

    Insight grant from Social Sciences and Humanities Research Council / Conseil de recherche en sciences humaines (Canada) Grant number : 435-2022-0638 IRB Approval : CEREP-22-091-D

    Usage Restrictions

    Full pseudonymization